Form 4: Medtronic Director Kendall J. Powell Acquires Shares and Restricted Stock Units

Director Kendall J. Powell reports acquisition of Medtronic shares and restricted stock units, increasing beneficial ownership.

Summary

• On April 29, 2024, Kendall J. Powell, a director of Medtronic plc, acquired 2,165 ordinary shares at a price of $80.86 per share.
• This acquisition was in the form of restricted stock units that vest on the one-year anniversary of the award date.
• Following the transaction, Powell's direct ownership of Medtronic ordinary shares increased to 46,035, which includes 877 shares acquired through dividend reinvestment since the last report.
• The report was signed by Thomas L. Osteraas, attorney-in-fact, on May 01, 2024.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing detailing a director's stock transactions. The acquisition could be seen as slightly positive, indicating confidence, but it's not a major event.

Positives

• The director's acquisition of shares may signal confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies like Medtronic. Investors often monitor these filings for signals about management's confidence in the company.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates